Related Experiment Videos
Summary
Methotrexate therapy for psoriasis can cause a severe lung condition. This hypersensitivity reaction, marked by respiratory distress and lung infiltrates, improved rapidly with corticosteroid treatment.
Area of Science:
- Pulmonary Medicine
- Dermatology
- Clinical Pharmacology
Background:
- Methotrexate is a common treatment for psoriasis.
- Adverse pulmonary reactions to methotrexate are rare but serious.
- This case highlights a severe, potentially life-threatening pulmonary syndrome.
Purpose of the Study:
- To report a case of severe pulmonary disease in a patient treated with methotrexate.
- To describe the clinical presentation, diagnostic features, and treatment response.
- To suggest a hypersensitivity reaction as the underlying mechanism.
Main Methods:
- Case report of a 40-year-old patient with psoriasis.
- Clinical observation of respiratory symptoms, fever, cough, dyspnea, and cyanosis.
- Radiographic evaluation (chest X-ray) showing bilateral infiltrates.
- Laboratory tests including blood eosinophilia assessment.
- Treatment with systemic corticosteroids.
Main Results:
- The patient developed acute respiratory distress with widespread bilateral pulmonary infiltrates.
- A notable discrepancy existed between physical examination and chest X-ray findings.
- Blood eosinophilia was present.
- Rapid clinical improvement was observed following administration of systemic corticosteroids.
Conclusions:
- The described pulmonary syndrome associated with methotrexate therapy may represent a hypersensitivity reaction.
- Prompt recognition and treatment with corticosteroids are crucial for managing this condition.
- Further investigation into methotrexate-induced lung disease is warranted.